drugset / Trial / NCT00358371
Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)
RandomizedCrossoverOpen-labelTreatment
Summary
Primary objective:To study the absolute bioavailability, distribution and elimination parameters of flucloxacillin from two oral formulations of flucloxacillin in healthy male and/or female subjects.
Timeline
- Start
- 2005-01-06
- Primary completion
- 2005-02-08
- Completion
- 2005-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FLOXACILLIN | Small molecule | 250 mg | Oral |
| Subject | FLOXACILLIN | Small molecule | 500 mg | Oral |